DCF Advisers, LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 197 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
DCF Advisers, LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$157,000
-10.3%
13,100
-6.4%
0.06%
-26.3%
Q1 2021$175,000
-19.7%
14,0000.0%0.08%
-15.6%
Q4 2020$218,000
-42.9%
14,000
-65.3%
0.09%
-53.8%
Q3 2020$382,000
-39.5%
40,400
-42.6%
0.20%
-44.8%
Q2 2020$631,000
+84.0%
70,400
+30.6%
0.35%
+57.6%
Q1 2020$343,000
-40.3%
53,900
-21.5%
0.22%
-38.6%
Q4 2019$575,00068,7000.36%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders